Conference on Implantable Auditory Prostheses
Conference on Implantable Auditory Prostheses
批准号:
10606813
负责人:
Jay T. Rubinstein
金额:
$4.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-01-01 至 2027-12-31
关键词:
AcousticsAdultAgeAtmosphereAuditoryAuditory Brain Stem ImplantsAuditory ProsthesisBasic ScienceCellular biologyChildCochlear ImplantsCochlear NerveCochlear nucleusCognitionCollaborationsCommunicationCommunitiesDevicesDisciplineElectrodesEngineeringEnvironmentEquityEsthesiaFaceFosteringFutureGoalsHearingHearing AidsHourImplantIndividualInternationalLanguage DevelopmentLengthLinguisticsLocationModificationMusicNoiseOrganizational ModelsParticipantPatientsPerceptionPerformancePhysiologyPopulationResearchResearch PersonnelResidual stateScheduleScienceScientistSeriesSocial NetworkSpeechSpeech DevelopmentSpeech PerceptionStructureSystemTimeVariantVestibular lossWorkclinical applicationcomorbiditycongenital deafnessdeafdesigneffective therapyhard of hearinghearing impairmentimprovedinterdisciplinary collaborationmaterials sciencemeetingsmemberneural prosthesispatient populationprogramssignal processingsoundsymposium
中文摘要
摘要
本申请寻求对2023年、2025年和2027年植入式听觉会议的部分支持
假体(CIAP)。2023年CIAP计划在太浩湖的Granlibakken会议中心举行,
CA,2023年7月9日至14日。人工耳蜗(CI)是第一个广泛应用于临床的神经假体,
恢复严重重听人群的声音感觉和言语理解,
助听器的选配方法在过去的30年里,
已经实现了患者使用这些装置的性能,因此更广泛的患者群体可以
从人工耳蜗中受益目前,植入语言后的平均语言理解得分
成年人在安静的环境中,句子识别的正确率接近80%,在低水平的环境中,正确率为50%。
背景噪音在2岁前接受CI的先天性耳聋儿童的听力恢复率接近正常
语言和语言的发展。CI甚至可以为成年人提供显著的沟通改善
他们有很强的残余听觉这些进步在很大程度上得益于集体
研究人员的努力,在广泛的科学学科,从细胞生物学,生理学,材料科学,
和信号处理,到语言学和认知。这种跨学科的协作与合作,
这在很大程度上是通过一系列两年一次的会议促成的,最初是1983年的戈登会议。这些
会议是与CI相关的唯一论坛,其中科学研究问题是活跃的唯一焦点。
听觉社区的参与者,他们为推动该领域的发展做出了贡献。即使是最好的CI用户,
在具有挑战性的听力中,
环境. CIAP的长期目标是产生尖端的研究想法,以改善设计,
听觉假体的功能。具体目标是:(1)为介绍提供一个全球论坛,
讨论最新和最高质量的研究,(2)有利于传播新的
通过科学讨论的发现,刺激新的研究方向,并通过以下方式促进合作
社交网络,以及(3)为年轻的调查人员和该领域的许多受训人员提供了一个展示其
与现有的调查人员合作并建立网络。CIAP会议使用戈登研究会议模式
组织,有足够的时间在程序中进行讨论,非结构化的时间,以鼓励自发
非正式的讨论和头脑风暴,以及一个孤立的“务虚会”地点,参与者花大部分时间
与其他与会者的清醒时间。
英文摘要
ABSTRACT
This application seeks partial support for the 2023, 2025, and 2027 Conferences on Implantable Auditory
Prostheses (CIAP). The 2023 CIAP is scheduled to be held at the Granlibakken Conference Center, Lake Tahoe,
CA, July 9-14, 2023. The cochlear implant (CI) is the first neural prosthesis in widespread clinical application for
restoring sound sensation and speech understanding to the severely hard-of-hearing population who have
difficulties understanding speech with acoustic hearing aids. Over the past 30 years, dramatic improvements in
patients' performance with these devices have been achieved and hence a wider population of patients can
benefit from cochlear implants. Currently the average speech understanding score for implanted postlingually
deafened adults is nearly 80% correct for sentence recognition in quiet and 50% correct in low levels of
background noise. Congenitally deaf children who receive a CI prior to age 2 are achieving nearly normal rates
of speech and language development. CIs can even provide significant improvement in communication for adults
who have substantial residual acoustic hearing. These advances have benefitted considerably from the collective
efforts of researchers in a broad array of scientific disciplines, from cellular biology, physiology, materials science,
and signal processing, to linguistics and cognition. This interdisciplinary collaboration and cooperation has been
fostered in large part through a series of biennial conferences, originating with a 1983 Gordon Conference. These
conferences are the only forum related to CIs in which scientific research issues are the sole focus of active
participants in the auditory community who contribute to moving the field forward. Even the best CI users though
face significant limitations in music perception as well as speech perception in challenging listening
environments. The long-term goal of CIAP is to generate cutting-edge research ideas to improve the design and
function of auditory prostheses. The Specific Aims are to provide (1) a global forum for the presentation and
discussion of the latest and highest quality research, (2) an atmosphere that is conducive to: disseminating new
findings through scientific discussion, stimulating new lines of research, and facilitating collaborations through
social networking, and (3) an opportunity for young investigators and many trainees in the field to present their
work and network with established investigators. CIAP conferences use the Gordon Research Conference model
of organization, with ample time for discussion within the program, unstructured time to encourage spontaneous
informal discussions and brainstorming, and an isolated “retreat” location where participants spend most of their
waking hours with other conference participants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of a human vestibular prosthesis
-
批准号:9107453
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2014
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimization of a human vestibular prosthesis
-
批准号:8895294
-
项目类别:
-
资助金额:$67.3万
-
财政年份:2014
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimization of a human vestibular prosthesis
-
批准号:9313231
-
项目类别:
-
资助金额:$57.7万
-
财政年份:2014
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimization of a human vestibular prosthesis
-
批准号:9530614
-
项目类别:
-
资助金额:$50.76万
-
财政年份:2014
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimized Conditioned Processing for Cochlear Implants
-
批准号:7167718
-
项目类别:
-
资助金额:$37.53万
-
财政年份:2006
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimized Conditioned Processing for Cochlear Implants
-
批准号:7546997
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2006
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimized Conditioned Processing for Cochlear Implants
-
批准号:7749927
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2006
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimized Conditioned Processing for Cochlear Implants
-
批准号:7035591
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2006
-
负责人:Jay T. Rubinstein
-
依托单位:
Optimized Conditioned Processing for Cochlear Implants
-
批准号:7336754
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2006
-
负责人:Jay T. Rubinstein
-
依托单位:
Ear Implant for Tinnitus Suppression
-
批准号:7040762
-
项目类别:
-
资助金额:$0.3万
-
财政年份:2004
-
负责人:Jay T. Rubinstein
-
依托单位:
COMPARATIVE BIOPHYSICAL MODEL OF SPIRAL GANGLION CELLS
-
批准号:2327984
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:Jay T. Rubinstein
-
依托单位:
海外基金